Patent · US Active

Cytomegalovirus vaccines and methods of production

US9439960B2 · kind B2 · utility

1Cited by
5References
3Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 1, 2008
Grant dateSep 13, 2016
Priority date—
Expiry dateOct 9, 2029

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2710/16164
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Methods of increasing diversity in cytomegalovirus vaccines through the selection of cell type in which the virus is propagated, and the use of cytomegalovirus produced by those methods in the development of vaccine compositions, are disclosed. Vaccine compositions comprising CMV isolated from epithelial cells are also disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.